Furthermore, research that included 52 ADPKD patients found that higher copeptin levels correlated with worse kidney outcomes (assessed by eGFR and TKV), while apelin, released in response to low plasma osmolality, inversely correlated with copeptin [22]. This evidence concerns the gene AVP and autosomal dominant polycystic kidney disease.